PRINCETON, N.J. (AP) — PRINCETON, N.J. (AP) — Amicus Therapeutics Inc. (FOLD) on Thursday reported a loss of $48.4 million in its first quarter.
On a per-share basis, the Princeton, New Jersey-based company said it had a loss of 16 cents. Losses, adjusted for non-recurring costs, came to 2 cents per share.
The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 6 cents per share.
The pharmaceutical company posted revenue of $110.4 million in the period, falling short of Street forecasts. Five analysts surveyed by Zacks expected $111.6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FOLD at https://www.zacks.com/ap/FOLD
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
